Critical Perspective: Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19, A Meta-analysis

When should we use IL-6 antagonists (Tociluzimab) in #COVID19 ? #BreatheEasy @ATSCritCare interviewed @msh_manu about his @JAMA_current article Podcast link: https://t.co/HKxN21tMgV They discuss #mortality, #LOS #infection risk & #steroid therapy https://t.co/K7GYQXWWzL